The identification of Syndecan-1/CD138 as a primary surface proteoglycan on MM cells prospected early on the potential pro-tumorigenic functions of upregulated surface proteoglycans (Fig. 4). This evidence concerns the gene SDC1 and Miyoshi myopathy.